Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | -- | 0.00 | 414,667 | 7.4M |
| Gross Profit | -- | 0.00 | -414,667 | 5.2M |
| Selling General And Administration | 106,026 | 388,410 | 690,592 | 994,516 |
| General And Administrative Expense | 106,026 | 388,410 | 690,592 | 994,516 |
| Other Operating Expenses | 12,506 | 16,465 | 7,273 | 44,626 |
| Operating Expense | 118,532 | 404,875 | 697,865 | 994,516 |
| Operating Income | -118,532 | -404,875 | -1.1M | -994,516 |
| EBIT | -118,532 | -404,875 | -1.1M | -994,516 |
| Interest Expense | -- | -- | -- | 40,801 |
| Interest Expense Non Operating | -- | -- | -- | 40,801 |
| Net Interest Income | -- | -2,275 | 846,131 | -240,979 |
| Other Income Expense | -- | 40,257 | -23.9M | 8.7M |
| Special Income Charges | -- | 0.00 | 580,882 | 8.7M |
| Gain On Sale Of Security | -- | 40,257 | -24.5M | -- |
| Earnings From Equity Interest | -- | -- | -- | 1.1M |
| Pretax Income | -118,532 | -364,618 | -24.1M | 7.5M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 2.3M |
| Net Income From Continuing And Discontinued Operation | -118,532 | -364,618 | -57.4M | 9.4M |
| Net Income From Continuing Operation Net Minority Interest | -118,532 | -364,618 | -24.1M | 7.5M |
| Net Income Including Noncontrolling Interests | -118,532 | -364,618 | -57.4M | 10.5M |
| Net Income Common Stockholders | -118,532 | -364,618 | -57.4M | 10.5M |
| Net Income | -118,532 | -364,618 | -57.4M | 10.5M |
| EBITDA | -118,532 | -404,875 | -1.1M | -985,590 |
| Normalized EBITDA | -118,532 | -445,132 | 22.8M | -9.7M |
| Reconciled Depreciation | -- | -- | 0.00 | 8,925 |
| Basic EPS | -0.03 | -0.15 | -82.19 | 15.09 |
| Diluted EPS | -0.03 | -0.15 | -82.19 | 15.09 |
| Basic Average Shares | 3.7M | 2.4M | 698,255 | 698,000 |
| Diluted Average Shares | 3.7M | 2.4M | 698,255 | 698,000 |
| Total Unusual Items | -- | 40,257 | -23.9M | 8.7M |
| Total Unusual Items Excluding Goodwill | -- | 40,257 | -23.9M | 8.7M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.27 |
| Normalized Income | -118,532 | -404,875 | -266,401 | 1.1M |
| Diluted NI Availto Com Stockholders | -118,532 | -364,618 | -57.4M | 10.5M |
| Gain On Sale Of Business | -- | -- | 0.00 | 133,877 |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 |
| Impairment Of Capital Assets | -- | 0.00 | -580,882 | -8.4M |
| Net Income Continuous Operations | -118,532 | -364,618 | -24.1M | 7.5M |
| Net Income Discontinuous Operations | -- | 0.00 | -33.2M | 2.0M |
| Net Income From Tax Loss Carryforward | -- | -- | 0.00 | 1.1M |
| Net Non Operating Interest Income Expense | -- | -2,275 | 846,131 | -240,979 |
| Other Gand A | 98,426 | 378,235 | 690,592 | 740,787 |
| Other Special Charges | -- | -- | -- | -117,302 |
| Reconciled Cost Of Revenue | -- | 0.00 | 414,667 | 7.4M |
| Salaries And Wages | 7,600 | 10,175 | 0.00 | 253,729 |
| Total Expenses | 118,532 | 404,875 | 1.1M | 994,516 |
| Total Other Finance Cost | -- | 2,275 | -846,131 | 240,979 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 311,350 | 337,067 | 9.7M | 9.4M |
| Cash Cash Equivalents And Short Term Investments | 311,350 | 337,067 | 9.7M | 9.4M |
| Cash Equivalents | -- | -- | -- | 0.00 |
| Cash Financial | 311,350 | 337,067 | 9.7M | 9.4M |
| Accounts Receivable | 448.00 | 1,244 | 5,108 | 0.00 |
| Receivables | 448.00 | 1,244 | 5,108 | 98,177 |
| Inventory | -- | -- | 0.00 | 48,451 |
| Prepaid Assets | 7,516 | 7,639 | 0.00 | 140,252 |
| Current Assets | 319,314 | 345,950 | 9.7M | 15.6M |
| Gross PPE | -- | -- | 4.8M | 6.1M |
| Accumulated Depreciation | -- | -- | -4.8M | -6.1M |
| Net PPE | -- | -- | 0.00 | 0.00 |
| Investments And Advances | -- | -- | -- | 0.00 |
| Long Term Equity Investment | -- | -- | -- | 0.00 |
| Total Non Current Assets | 22,545 | 30,061 | 0.00 | 0.00 |
| Total Assets | 341,859 | 376,011 | 9.7M | 15.6M |
| Current Debt | -- | -- | -- | 1.6M |
| Current Debt And Capital Lease Obligation | -- | -- | -- | 1.6M |
| Accounts Payable | 31,985 | 37,105 | 124,987 | 216,753 |
| Payables | 31,985 | 37,105 | 9.6M | 216,753 |
| Payables And Accrued Expenses | 31,985 | 37,105 | 9.6M | 216,753 |
| Current Deferred Revenue | -- | -- | -- | 291,980 |
| Other Current Liabilities | -- | -- | -- | 3.2M |
| Current Liabilities | 31,985 | 37,105 | 9.6M | 5.2M |
| Long Term Debt | -- | -- | -- | 367,206 |
| Long Term Debt And Capital Lease Obligation | -- | -- | -- | 367,206 |
| Long Term Capital Lease Obligation | -- | -- | -- | 0.00 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 856,813 |
| Total Liabilities Net Minority Interest | 31,985 | 37,105 | 9.6M | 6.1M |
| Common Stock | 48.6M | 48.5M | 48.0M | 79.1M |
| Capital Stock | 48.6M | 48.5M | 48.0M | 79.1M |
| Additional Paid In Capital | -- | -- | 5.5M | 7.0M |
| Retained Earnings | -54.8M | -54.7M | -54.3M | -23.3M |
| Gains Losses Not Affecting Retained Earnings | 6.5M | 6.5M | 6.5M | -50.5M |
| Other Equity Adjustments | 6.5M | 6.5M | 6.5M | -50.5M |
| Common Stock Equity | 309,874 | 338,906 | 193,349 | 9.5M |
| Stockholders Equity | 309,874 | 338,906 | 193,349 | 9.5M |
| Total Equity Gross Minority Interest | 309,874 | 338,906 | 193,349 | 9.5M |
| Total Capitalization | 309,874 | 338,906 | 193,349 | 9.9M |
| Net Tangible Assets | 309,874 | 338,906 | 193,349 | 9.5M |
| Tangible Book Value | 309,874 | 338,906 | 193,349 | 9.5M |
| Working Capital | 287,329 | 308,845 | 193,349 | 10.4M |
| Invested Capital | 309,874 | 338,906 | 193,349 | 11.5M |
| Total Debt | -- | -- | -- | 1.9M |
| Share Issued | 3.8M | 3.5M | 698,255 | 698,256 |
| Ordinary Shares Number | 3.8M | 3.5M | 698,255 | 698,256 |
| Accrued Interest Receivable | -- | -- | -- | 2,550 |
| Assets Held For Sale Current | -- | -- | 0.00 | 5.9M |
| Capital Lease Obligations | -- | -- | -- | 0.00 |
| Current Capital Lease Obligation | -- | -- | -- | 0.00 |
| Current Deferred Liabilities | -- | -- | 0.00 | 291,980 |
| Duefrom Related Parties Non Current | -- | -- | 0.00 | 0.00 |
| Finished Goods | -- | -- | 0.00 | 5,100 |
| Long Term Provisions | -- | -- | -- | 489,608 |
| Machinery Furniture Equipment | -- | -- | 1.0M | 1.3M |
| Non Current Prepaid Assets | 22,545 | 30,061 | 0.00 | 0.00 |
| Other Current Borrowings | -- | -- | -- | 1.6M |
| Other Equity Interest | -- | -- | -- | -2.8M |
| Other Payable | -- | -- | 9.4M | -- |
| Other Properties | -- | -- | 1.0M | 1.0M |
| Properties | -- | -- | 3.7M | 4.8M |
| Raw Materials | -- | -- | 0.00 | 43,351 |
| Taxes Receivable | -- | -- | 4,000 | 95,626 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -107,617 | -452,161 | 2.2M | 6.3M |
| Cash Flow From Continuing Operating Activities | -107,617 | -452,161 | 2.6M | 6.3M |
| Depreciation And Amortization | -- | -- | 0.00 | 8,925 |
| Depreciation Amortization Depletion | -- | -- | 0.00 | 8,925 |
| Stock Based Compensation | 7,600 | 10,175 | 0.00 | -- |
| Change In Working Capital | 3,315 | -97,718 | 78,267 | 7.1M |
| Changes In Account Receivables | -- | -- | 0.00 | 178,503 |
| Change In Receivables | 796.00 | 3,864 | -572.74 | 7.7M |
| Change In Payables And Accrued Expense | -5,120 | -63,882 | 42,970 | -548,259 |
| Change In Payable | -5,120 | -63,882 | 42,970 | -548,259 |
| Change In Other Working Capital | -- | -- | -- | 291,980 |
| Other Non Cash Items | -- | -- | 10,858 | 24,225 |
| Capital Expenditure | -- | -- | -- | -478,132 |
| Purchase Of PPE | -- | -- | -- | -478,132 |
| Net PPE Purchase And Sale | -- | -- | -- | -478,132 |
| Sale Of Business | -- | 0.00 | 3.5M | 263,929 |
| Investing Cash Flow | -- | 0.00 | 6.7M | 828,763 |
| Cash Flow From Continuing Investing Activities | -- | 0.00 | 7.1M | 828,763 |
| Issuance Of Debt | -- | -- | -- | 1.0M |
| Repayment Of Debt | -- | 0.00 | -4.7M | -4.7M |
| Net Issuance Payments Of Debt | -- | 0.00 | -4.7M | -4.7M |
| Issuance Of Capital Stock | 0.00 | 476,000 | 0.00 | -- |
| Repurchase Of Capital Stock | 0.00 | -9.4M | 0.00 | -- |
| Net Common Stock Issuance | 0.00 | 476,000 | 0.00 | -- |
| Financing Cash Flow | 81,900 | -9.0M | -4.9M | -4.7M |
| Cash Flow From Continuing Financing Activities | 81,900 | -9.0M | -4.7M | -4.7M |
| Effect Of Exchange Rate Changes | -- | -27,722 | -748,410 | -204,003 |
| Changes In Cash | -25,717 | -9.4M | 507,239 | 4.0M |
| Beginning Cash Position | 337,067 | 9.7M | 10.0M | 5.6M |
| End Cash Position | 311,350 | 337,067 | 9.8M | 9.4M |
| Free Cash Flow | -107,617 | -452,161 | 2.2M | 6.3M |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 0.00 | 0.00 | 105,862 | 145,352 |
| Asset Impairment Charge | -- | -- | -580,882 | -8.4M |
| Cash Flow From Discontinued Operation | -- | 0.00 | -957,309 | 1.5M |
| Cash From Discontinued Financing Activities | -- | 0.00 | -217,152 | -- |
| Cash From Discontinued Investing Activities | -- | 0.00 | -369,158 | -- |
| Cash From Discontinued Operating Activities | -- | 0.00 | -370,999 | -- |
| Change In Prepaid Assets | 7,639 | -37,700 | 35,869 | 8,925 |
| Common Stock Issuance | 0.00 | 476,000 | 0.00 | -- |
| Depletion | -- | -- | -- | 81,601 |
| Depreciation | -- | -- | 0.00 | 8,925 |
| Dividend Received Cfo | -- | 0.00 | 2.8M | 7.5M |
| Earnings Losses From Equity Investments | -- | -- | 0.00 | -986,865 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 |
| Interest Paid Cfo | -- | -- | 8,000 | -3,825 |
| Interest Received Cfo | -- | 0.00 | 10,858 | -- |
| Long Term Debt Issuance | -- | -- | -- | 1.0M |
| Long Term Debt Payments | -- | 0.00 | -4.7M | -4.7M |
| Net Business Purchase And Sale | -- | 0.00 | 3.5M | 263,929 |
| Net Foreign Currency Exchange Gain Loss | -- | 0.00 | 24.5M | 0.00 |
| Net Income From Continuing Operations | -118,532 | -364,618 | -24.1M | 8.6M |
| Net Long Term Debt Issuance | -- | 0.00 | -4.7M | -4.7M |
| Net Other Investing Changes | -- | -- | 3.5M | 564,834 |
| Net Preferred Stock Issuance | 0.00 | -9.4M | 0.00 | -- |
| Operating Gains Losses | -- | -- | 23.9M | -986,865 |
| Preferred Stock Payments | 0.00 | -9.4M | 0.00 | -- |
| Proceeds From Stock Option Exercised | 81,900 | 0.00 | -- | -- |
| Sale Of PPE | -- | -- | -- | 0.00 |